Choong-wae to conduct large-scale clinical study with pitavastatin
Published: 2009-07-16 06:57:00
Updated: 2009-07-16 06:57:00
Choong-wae Pharm announced on July 14 that it will conduct the first clinical trial specifically designed to study the efficacy of pitavastatin that may reduce the risk of cardiovascular events in 2,000 Korean patients with diabetes.
The five-year randomized study, which will be funded by the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
